SMARCA1 Peptide - N-terminal region (AAP36528)

Aviva Systems Biology

SMARCA1 Peptide - N-terminal region (AAP36528)

23

Research Use Only

Lyophilized powder

Probable global transcription activator SNF2L1

This is a synthetic peptide designed for use in combination with anti-SMCA1 Antibody (ARP36528_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

-20°C

12352202